Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody

This publication has 42 references indexed in Scilit:

• Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
  Journal of Nuclear Medicine, 2010
• Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-d-GEEEK
  Nuclear Medicine and Biology, 2009
• Properties, production, and applications of camelid single-domain antibody fragments
  Applied Microbiology and Biotechnology, 2007
• Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice
  The FASEB Journal, 2006
• Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues
  Nuclear Medicine and Biology, 2006
• Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131i]iodo-4-phosphonomethylbenzoate ([131i]SIPMB), a negatively charged substituent bearing acylation agent
  Nuclear Medicine and Biology, 2004
• N-Succinimidyl 3-[¹³¹I]Iodo-4-phosphonomethylbenzoate ([¹³¹I]SIPMB), a Negatively Charged Substituent-Bearing Acylation Agent for the Radioiodination of Peptides and mAbs
  Bioconjugate Chemistry, 2003
• HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: Comparison of results and correlation with survival
  Molecular Diagnosis, 2000
• Intracellular catabolism of radiolabeled anti-CD3 antibodies by leukemic T cells
  Cellular Immunology, 1991
• Radioiodinated B6.2 monoclonal antibody: Further characterization of a potential radiopharmaceutical for the identification of breast tumors
  International Journal of Nuclear Medicine and Biology, 1985